ECL

Business Context and Reporting Period

Company: Ecolab Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2006
Business Overview: Ecolab provides water, hygiene, and energy technologies and services to customers in the food, beverage, hospitality, healthcare, and industrial sectors. The company operates through United States Cleaning & Sanitizing, United States Other Services, and International segments.

Key Financial Metrics

Amounts in thousands, except per share data.

Margins (Q3 2006 vs Q3 2005):
- Gross Profit Margin: 51.1% vs 50.8%
- Operating Margin: 14.2% vs 14.0%
- Effective Tax Rate: 35.1% vs 35.1%

Material Changes vs. Prior Period

• Revenue Growth: Consolidated net sales increased 10% in Q3 2006 and 7% for the nine-month period. Growth was driven by volume, pricing, and favorable foreign currency translation (which added 2 percentage points to Q3 growth).
• Profitability: Net income rose 13% in Q3 and 13% for the nine-month period. Diluted EPS increased 13% in Q3 and 14% year-to-date.
• Segment Performance:
  • U.S. Cleaning & Sanitizing: Sales up 10% (Q3) and 10% (9M). Operating income up 15% in both periods.
  • U.S. Other Services: Sales up 10% (Q3) and 9% (9M), led by 15% growth in Pest Elimination.
  • International: Sales up 6% at fixed currency rates (Q3) and 5% (9M). Operating income up 3% (Q3) and 7% (9M) at fixed rates.
• Balance Sheet: Total assets increased $210 million from year-end 2005, primarily due to currency translation effects and business acquisitions. Total debt decreased to $733 million from $746 million at year-end 2005.
• Cash Flow: Operating cash flow for the nine months ended Sep 30, 2006, was $404 million, down from $422 million in 2005, largely due to a $45 million voluntary pension contribution in Q1 2006.

Guidance, Outlook, and Risks

• Outlook: Management expects raw material costs to increase through the remainder of 2006 but anticipates the year-over-year increase will be lower than in 2005. The effective income tax rate is expected to approximate 35% for the full year 2006.
• Capital Allocation: The company repurchased approximately $251 million (6.3 million shares) of common stock in the first nine months of 2006. Dividends declared were $0.10 per share in Q3 and $0.30 for the nine months.
• Acquisitions: Acquired Shield Medicare Ltd. (UK) and DuChem Industries (US) in 2006. Subsequent to quarter-end, acquired Powles Hunt & Sons International Ltd.'s U.K. commercial laundry business.
• Debt Refinancing: Entered a private placement for €300 million ($381 million) senior notes in July 2006 to refinance €300 million Euronotes due in February 2007.
• Accounting Changes:
  • SFAS 158: Adoption required at year-end 2006. Estimated impact is a $200 million reduction in net assets on the balance sheet with no impact on income or cash flows.
  • FIN 48: Adoption required Jan 1, 2007. Impact currently being evaluated.
• Risks: Exposure to foreign currency fluctuations, raw material cost increases, and potential impacts from new accounting standards. No material changes to risk factors reported since the 2005 10-K.

Investor Verification Checklist

• Share Repurchases: Verify the remaining authorization under the share repurchase program (3.5 million shares remaining as of Sep 30, 2006, plus a new 10 million share authorization approved Oct 26, 2006).
• Debt Maturity: Confirm the refinancing of the €300 million Euronotes due February 2007 with the new private placement notes.
• Pension Obligations: Monitor the impact of SFAS 158 adoption on the balance sheet at year-end 2006, specifically the estimated $200 million reduction in net assets.
• Raw Material Costs: Track the realization of management's expectation that raw material cost increases will be lower in 2006 compared to 2005.
• Acquisition Integration: Assess the contribution of recent acquisitions (Shield Medicare, DuChem, Powles Hunt) to future revenue growth.